Globus Medical Inc
NYSE:GMED

Watchlist Manager
Globus Medical Inc Logo
Globus Medical Inc
NYSE:GMED
Watchlist
Price: 83.56 USD -1.02% Market Closed
Market Cap: 11.3B USD
Have any thoughts about
Globus Medical Inc?
Write Note

Globus Medical Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Globus Medical Inc
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Globus Medical Inc
NYSE:GMED
Total Liabilities
$1B
CAGR 3-Years
74%
CAGR 5-Years
55%
CAGR 10-Years
27%
Becton Dickinson and Co
NYSE:BDX
Total Liabilities
$31.4B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
16%
Boston Scientific Corp
NYSE:BSX
Total Liabilities
$17.4B
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
6%
Stryker Corp
NYSE:SYK
Total Liabilities
$23.7B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Total Liabilities
$34.6B
CAGR 3-Years
-4%
CAGR 5-Years
-1%
CAGR 10-Years
6%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Liabilities
$2.2B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
14%
No Stocks Found

Globus Medical Inc
Glance View

Market Cap
11.4B USD
Industry
Health Care
Economic Moat
None

Globus Medical Inc., founded in 2003, has crafted a distinctive narrative in the landscape of medical technology, rooted in innovation and practicality. Emerging from a profound understanding of spinal pathologies, the company has steadily risen to become a pivotal player in the musculoskeletal sector. Its journey is steered by a commitment to addressing complex spine disorders through the development of cutting-edge products that are not only innovative but also substantially user-friendly for both surgeons and patients. This fusion of technology and practicality is what sets Globus Medical apart. The company relentlessly focuses on expanding its product offerings through significant investments in research and development, continuously pushing the envelope in areas such as minimally invasive surgery, advanced surgical approaches, and imaging, which form the core of its business operations. The heart of Globus Medical's revenue model lies in its expansive product portfolio that serves surgeons and healthcare institutions globally. Their financial engine is powered by the sales of implants and related surgical instruments, meticulously designed to improve surgical outcomes. These products span a wide array of offerings including but not limited to advanced minimally invasive techniques and sophisticated trauma solutions. Beyond the traditional revenue streams, Globus Medical has ventured into promising areas like robotic surgery, thereby augmenting its revenue sources while accessing the benefits of technological advancements. This strategic direction not only strengthens its market position but also ensures it stays at the forefront of providing value-based solutions in the ever-evolving healthcare landscape. By integrating its technological prowess with a deep understanding of clinical needs, Globus Medical continues to carve a robust path for sustainable growth and leadership in the medtech sector.

GMED Intrinsic Value
82.52 USD
Overvaluation 1%
Intrinsic Value
Price

See Also

What is Globus Medical Inc's Total Liabilities?
Total Liabilities
1B USD

Based on the financial report for Sep 30, 2024, Globus Medical Inc's Total Liabilities amounts to 1B USD.

What is Globus Medical Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
27%

Over the last year, the Total Liabilities growth was -13%. The average annual Total Liabilities growth rates for Globus Medical Inc have been 74% over the past three years , 55% over the past five years , and 27% over the past ten years .

Back to Top